SSA
MRNA icon

Schonfeld Strategic Advisors’s Moderna MRNA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-150,000
Closed -$6.24M – 2389
2024
Q4 		$6.24M Buy
+150,000
New +$7.17M 0.04% 429
2023
Q1 		– Sell
-100,000
Closed -$152K – 2430
2022
Q4 		$152K Buy
+100,000
New +$16.4M ﹤0.01% 2077

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors's MRNA Position: Q1 2026 in Review

Schonfeld Strategic Advisors reduced its Moderna (MRNA) stake by 28% in Q1 2026, selling an estimated $284K and leaving 15,691 shares worth $797K. The position accounts for 0.01% of the portfolio, ranked #1199.

Schonfeld Strategic Advisors first reported a position in MRNA in Q1 2020 and has held it in 19 quarters since. The position peaked at $16.5M in Q2 2024. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Schonfeld Strategic Advisors held 15,691 shares of Moderna worth $797K as of Q1 2026.
  • Schonfeld Strategic Advisors sold 6,086 Moderna shares in Q1 2026, an estimated $284K.
  • Moderna made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1199 holding.
  • Schonfeld Strategic Advisors first reported a position in Moderna in Q1 2020 and has held it in 19 quarters since.
  • Schonfeld Strategic Advisors's Moderna position peaked at $16.5M in Q2 2024.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.